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Gene networkIn C. elegans the 4-cell stage blastomere EMS is an endomesodermal precursor. Its anterior daughter, MS,
makes primarily mesodermal cells, while its posterior daughter E generates the entire intestine. The gene
regulatory network underlying speciﬁcation of MS and E has been the subject of study for more than
15 years. A key component of the speciﬁcation of the two cells is the involvement of the Wnt/β-catenin
asymmetry pathway, which through its nuclear effector POP-1, speciﬁes MS and E as different from each
other. Loss of pop-1 function results in the mis-speciﬁcation of MS as an E-like cell, because POP-1 directly
represses the end-1 and end-3 genes in MS, which would otherwise promote an endoderm fate. A long-
standing question has been whether POP-1 plays a role in specifying MS fate beyond repression of endoderm
fate. This question has been difﬁcult to ask because the only chromosomal lesions that remove both end-1
and end-3 are large deletions removing hundreds of genes. Here, we report the construction of bona ﬁde
end-1 end-3 double mutants. In embryos lacking activity of end-1, end-3 and pop-1 together, we ﬁnd that
MS fate is partially restored, while E expresses early markers of MS fate and adopts characteristics of both MS
and C. Our results suggest that POP-1 is not critical for MS speciﬁcation beyond repression of endoderm
speciﬁcation, and reveal that Wnt-modiﬁed POP-1 and END-1/3 further reinforce E speciﬁcation by
repressing MS fate in E. By comparison, a previous work suggested that in the related nematode C. briggsae,
Cb-POP-1 is not required to repress endoderm speciﬁcation in MS, in direct contrast with Ce-POP-1, but is
critical for repression of MS fate in E. The ﬁndings reported here shed new light on the ﬂexibility of
combinatorial control mechanisms in endomesoderm speciﬁcation in Caenorhabditis.
© 2009 Elsevier Inc. All rights reserved.Introduction
Combinatorial control, achieved through spatiotemporally precise
activation of genes in regulatory networks, is a central mechanism by
which cells choose appropriate pathways of cell speciﬁcation in
metazoan development. Elucidation of such networks allows an
appreciation for the complexity of the instructions encoded in the
genome that bring about embryogenesis from the zygote. The
endomesoderm speciﬁcation network in the nematode C. elegans
is a model for such networks in general. While an exhaustive
compendium of protein–DNA interactions has yet to be made, many
years of forward and reverse genetics, transcriptome analysis and
protein–DNA studies have revealed a core network that includes
motifs found in many other similar networks, such as feed-forward
loops and autoregulation (Maduro, 2006). Evolutionary comparisonste the 50th anniversary of
mental Biology, UC Riverside,
ll rights reserved.of this network have begun to be performed in related nematodes,
and important similarities and differences have been identiﬁed
(Coroian et al., 2005; Lin et al., 2009).
In C. elegans, the 4-cell stage blastomere EMS is an endomesoderm
precursor: its anterior daughter, MS, generates some 80 cells that are
primarily mesodermal, which includes a portion of the body muscles,
many posterior cells of the pharynx, and four embryonically-derived
coelomocytes (Fig. 1A) (Sulston et al., 1983). Its posterior sister E is
the sole endoderm progenitor and generates 20 intestinal cells.
Speciﬁcation of MS and E involves the participation of two pathways
that work in parallel (Fig. 1B): the SKN-1 pathway assigns
endomesodermal identity to the EMS daughters, while the Wnt/β-
catenin asymmetry pathway directs the two cells to adopt different
fates (Bowerman et al., 1992; Lin et al., 1995; Maduro and Rothman,
2002; Mizumoto and Sawa, 2007; Rocheleau et al., 1997; Rocheleau
et al., 1999; Thorpe et al., 1997).
Endomesoderm speciﬁcation begins with maternal SKN-1, a
bZIP/homeodomain transcription factor that is present in the nuclei
of EMS and its sister P2 at the 4-cell stage (Bowerman et al., 1993).
Loss of SKN-1 leads to mis-speciﬁcation of MS all the time, and E
most (∼70–80%) of the time (Bowerman et al., 1992). In addition to
the MS-derived posterior portion of the pharynx, mutants for skn-1
Fig. 1. The early C. elegans lineage and an abbreviated version of the endomesoderm gene regulatory network. (A) An abbreviated lineage shows the origin of the six founder cells
and tissues made by each, with numbers of cells for gut, pharynx, muscle and coelomocytes in brackets (Sulston et al., 1983). Diagrams of an 8-cell stage embryo and larva show the
lineal origins of the components of the digestive tract: Foregut/pharynx, midgut, and hindgut/rectum (h.g.). The assignment of ABa to ‘anterior’ pharynx and MS to ‘posterior’
pharynx is convenient but not strictly correct (Priess et al., 1987). On the larva, coelomocytes are indicated by ‘CC’. (B) A ﬂow diagram depicts a simpliﬁed version of the
endomesoderm gene regulatory network, showing combinatorial control through the SKN-1 and Wnt/β-catenin pathways (Broitman-Maduro et al., 2009; Maduro, 2008).
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GLP-1/Notch-dependent cell–cell interaction between MS and
descendants of the AB founder cell (Mello et al., 1994; Priess et al.,
1987). Within EMS, SKN-1 activates expression of a presumptive
ligand for this interaction and the med-1,2 divergent GATA factor
gene pair (Lowry et al., 2009; Maduro et al., 2001). Loss of med-1,2
together results in a penetrant mis-speciﬁcation of MS, and low-
penetrance mis-speciﬁcation of E, owing to parallel inputs into E
speciﬁcation (Broitman-Maduro et al., 2009; Goszczynski and
McGhee, 2005; Maduro et al., 2007; Maduro et al., 2001). Within
the early MS lineage, the MEDs activate the T-box gene tbx-35, and
TBX-35 (perhaps in combination with another factor) activates the
NK-2 homeobox gene ceh-51 (Broitman-Maduro et al., 2009). Loss of
tbx-35 and ceh-51 together results in a penetrant mis-speciﬁcation
of MS that resembles the MS phenotype of med-1,2 mutants
(Broitman-Maduro et al., 2009). TBX-35 and CEH-51 are hypothe-
sized to activate further pathways that lead to speciﬁcation of
pharynx, muscle and other tissues made by MS. Pharynx speciﬁca-
tion involves activation of a gene network with PHA-4/FoxA at the
top (Gaudet and Mango, 2002), and which includes the pharynx
muscle-speciﬁc regulator CEH-22/Nkx2.5 (Okkema and Fire, 1994).
Muscle speciﬁcation occurs via a three-way collaboration of HND-1/
Hand, HLH-1/MyoD and UNC-120/Srf (Fukushige et al., 2006) and
activation of a muscle gene network (Roy et al., 2002).
Within the early E lineage, theMEDs, SKN-1, theWnt effector POP-
1/TCF, and PAL-1/Caudal contribute to endoderm speciﬁcation
through activation of the GATA factor genes end-1 and end-3.
Expression of end-3 occurs slightly earlier than end-1 and there is
evidence that END-3 also contributes to end-1 activation (Baugh et al.,
2003; Maduro et al., 2007). Downstream of end-1,3, the principal
target is the GATA factor gene elt-2 (Fukushige et al., 1998), which
activates a network of targets for intestinal development (McGhee et
al., 2009; McGhee et al., 2007; Pauli et al., 2006).
For both MS and E, loss of function of SKN-1, the MEDs, ENDs or
TBX-35/CEH-51 causes adoption of a C-like fate by the mis-speciﬁed
blastomeres. In contrast, mutations in the Wnt/β-catenin asymmetry
pathway, which makes MS and E different, result in either an MS to E
transformation (a ‘Pop’ phenotype) or the reverse, an E to MS
transformation (a ‘Mom’ phenotype). Speciﬁcation of E requires a
cell–cell interaction between EMS and its sister P2 (Goldstein, 1992).
This interaction involves overlapping Wnt/MAPK/Src pathways and
ultimately results in differential modiﬁcation of the nuclear effector
POP-1/TCF (Bei et al., 2002; Lin et al., 1998; Lin et al., 1995; Meneghiniet al., 1999; Rocheleau et al., 1997; Rocheleau et al., 1999; Shin et al.,
1999; Thorpe et al., 1997). This modiﬁcation results in the nuclear
export of POP-1 in E (a phenomenon called ‘POP-1 asymmetry’),
lowering its concentrations relative to the divergent β-catenin SYS-1,
and permitting it to function as an activator in E (Huang et al., 2007;
Maduro et al., 2002; Phillips et al., 2007). Within MS, the high nuclear
levels of POP-1 allow it to repress end-1 and end-3, while in E, POP-1
contributes to activation of (at least) end-1 (Maduro et al., 2005b;
Maduro et al., 2002; Shetty et al., 2005). Mutations in the upstream
Wnt/MAPK/Src components result in a Mom phenotype, while loss of
pop-1 is epistatic to Mom mutants and results in a Pop phenotype.
POP-1 and theWnt/β-catenin asymmetry pathway form a switch that
is used multiple times in C. elegans development (Kaletta et al., 1997;
Lin et al., 1998; Mizumoto and Sawa, 2007).
Outside of the EMS lineage, multiple parallel pathways block
activity of SKN-1 or promote its degradation (Bei et al., 2002; Lin,
2003; Maduro et al., 2001; Mello et al., 1992; Page et al., 2007;
Shirayama et al., 2006). For example, the CCCH zinc ﬁnger protein PIE-
1 blocks activity of SKN-1 in P2: loss of pie-1 function results in an
ectopic mis-speciﬁcation of the P2 daughters as MS- and E-like (Mello
et al., 1992). Similarly, a gain-of-function mutation in oma-1, which
encodes a zinc ﬁnger protein similar to PIE-1, results in ectopic mis-
speciﬁcation of the C blastomere as an EMS-like cell, due to increased
concentrations of SKN-1 in C (Lin, 2003).
The POP-1 switching system in C. elegans participates in the MS/E
decision primarily by repressing endoderm speciﬁcation in MS,
although it makes a weaker contribution to endoderm speciﬁcation in
E (Lin et al., 1995; Shetty et al., 2005). In the related nematode,
C. briggsae, analysis of the Cb-pop-1 and Cb-skn-1 RNAi phenotypes led
to the conclusion that Cb-POP-1 contributes to MS and E speciﬁcation
primarily as an essential activator of the Cb-end genes in E, with a
parallel function in MS speciﬁcation with Cb-SKN-1 (Lin et al., 2009).
This observation, alongwith other observations regarding expression of
MS factors in pop-1-depleted embryos (Broitman-Maduro et al., 2006;
Broitman-Maduro et al., 2009), prompted us to examine the role of
C. elegans POP-1 in MS outside of repression of endoderm speciﬁcation.
Here, we describe the construction of chromosomal end-1 end-3
double mutants, and from a fully penetrant gut defect, conclude that
these two genes are completely essential for endoderm speciﬁcation
in C. elegans. We test the requirement for POP-1 in MS speciﬁcation
outside of repression of the ends, and ﬁnd that loss of pop-1 function
in end-3 single mutants, and end-1,3 double mutants, results in an
apparent restoration of some aspects of MS speciﬁcation to the MS
Table 1
Endoderm speciﬁcation in wild-type and mutant strains.
Genotype % of embryos containing
endoderma
Wild-type (N2) 100% (N500)
end-1(ok558) 100% (322)
end-3(ok1448) 95% (155)
end-3(zu247) 91% (247)
end-1(ok558) end-3(ok1448) 0% (190)
end-1(ok558) end-3(zu247) 0% (377)
end-1(ok558) end-3(ok1448); Ex[end-1,3(+)] 99% (134)
end-1(ok558) end-3(zu247); Ex[end-1,3(+)] 96% (83)
end-1(ok558) end-3(ok1448); pie-1(RNAi) 0% (49)
end-1(ok558) end-3(zu247); pie-1(RNAi) 0% (72)
end-3(zu247); pop-1(RNAi) 3% (175)
end-3(ok1448); pop-1(zu189)b 9% (274)
end-3(ok1448); pop-1(RNAi) 1% (262)
end-1(ok558) end-3(zu247); pop-1(RNAi) 0% (51)
end-1(ok558) end-3(ok1448); pop-1(RNAi) 0% (127)
end-1(ok558) end-3(ok1448); pop-1(zu189)b 0% (34)
a Some data were previously reported in Maduro et al. 2005b.
b Embryos were also homozygous for dpy-5(e61).
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and C-like tissues. Loss of end-1,3, or loss of pop-1, results in
derepression of MS speciﬁcation genes in the early E lineage, implying
other functions for these regulators in E. These ﬁndings are integrated
into an updated model for the C. elegans endomesoderm gene
speciﬁcation network, and are discussed in terms of a hierarchy of
competing cell speciﬁcation pathways and evolutionary ﬂexibility in
combinatorial control.
Materials and methods
Mutations and transgenic strains
Mutants: LG X: med-1(ok804). I: pop-1(zu189), dpy-5(e61). II:
tbx-35(tm1789). III: med-2(cx9744), unc-119(ed3), unc-119(ed4). IV:
him-8(e1498). V: end-1(ok558), end-3(ok1448), end-3(zu247), dpy-
11(e224), unc-76(e911), him-5(e1490), ceh-51(tm2123). Rearrange-
ments: hT1 [I;V]. Mapped reporters: wIs84 [elt-2::GFP] X, gvIs402
[unc-120::GFP] I, cdIs42 [cup-4::GFP] I, cdIs41 [cup-4::GFP] II, ruIs37
[myo-2::GFP] III, pxIs6 [pha-4::GFP] IV, cuIs1 [ceh-22::GFP] V. Un-
mapped: qtIs9 [nhr-25::YFP], wIs117 [med-1::GFP::POP-1]. Extrachro-
mosomal arrays: teEx226 [tbx-35::GFP], teEx420 [med-1::GFP::SYS-1].
All pop-1(zu189) chromosomes also carried dpy-5(e61), permitting
identiﬁcation of homozygous zu189mothers by their Dpy phenotype.
Construction of end-1 end-3 double mutant strains
We constructed a dpy-11 end-1 unc-76 triple mutant using
standard methods (Fay, 2006) and conﬁrmed homozygosity of ok558
by PCR. We obtained dpy-11 end-1 unc-76/end-3(ok1448) hetero-
zygotes after crossing with end-3(ok1448) males, fromwhich 120 Dpy
non-Unc self progeny were singled. Two of these segregated ∼25%
dead eggs lacking endoderm. We injected one of these with end-3(+)
(pMM214) and unc-119::CFP (pMM809) to generate a dpy-11 end-
1,3; Ex[CFP] line. PCR was used to conﬁrm the presence of ok558 and
ok1448 and absence of wild-type chromosomal end-1 and end-3
sequences (primer sequences are available on request). A similar
strategy was used to recover a dpy-11 end-1 end-3(zu247) strain from
93 Dpy non-Unc progeny of dpy-11 end-1 unc-76/end-3(zu247)
heterozygotes. Strains were backcrossed to N2 to remove dpy-11,
and derivative strains marked with unc-119::YFP (pMM531), unc-
119::mCherry (pMM824) or sur-5::dsRed (pAS152) in the rescuing
arrays were made by microinjection to replace the CFP-expressing
array. Such strains are superﬁcially wild-type and segregate arrested
embryos and larvae that lack the transgene array. In total, three
independent end-1,3 double mutants were isolated at a frequency of
1.4% (n=213), comparable to the predicted frequency of 1.5%
obtained by subtracting the end-1 and end-3 interpolated genetic
positions and dividing by the dpy-11 unc-76 genetic distance in
WormBase (WS200).
To introduce the end-1(ok558) end-3(ok1448) chromosome into a
pop-1(zu189) strain, males from MS749 [pop-1 dpy-5/hT1[I;V] I;
ruIs37 unc-119 III; him-5/him-5 hT1[I;V] V] were crossed to end-1,3;
Ex[unc-119::CFP] hermaphrodites. F1 CFP(+) males were crossed to
MS749 to generate strain MS1172 [pop-1 dpy-5/hTI I; ruIs37 III; end-
1,3/him-5 hT1 V]. From 50 singled wild-type CFP(+) MS1172
hermaphrodites, we obtained three isolates of genotype pop-1 dpy-
5/hT1 I; end-1,3/end-1,3 hT1 V; ruIs37 III; Ex[unc-119::CFP] as
conﬁrmed by the absence of CFP(−) progeny that contained gut.
A med-1,2; end-1,3 mutant strain was made as follows. med-1;
med-2 males rescued by an unc-119::CFP array carrying med-1(+)
were crossed to a dpy-11 end-1 end-3; pha-4::GFP strain rescued by
an array carrying end-3(+) and unc-119::YFP. Dpy F2 hermaphrodites
expressing YFP, CFP and GFP were singled to identify those showing
complete transgene dependence on the med (+) and end (+) arrays,
and which showed 100% transmission of pha-4::GFP. The two arrayswere replaced by a single array expressing unc-119::mCherry and
which carried cosmids T24D3 (med-1(+)) and F58E10 (end-1,3(+)).
A cup-4::GFP version was made using a similar strategy.
To make a tbx-35; end-1 end-3 ceh-51 strain, we ﬁrst constructed
++ ceh-51/end-1 end-3+ hermaphrodites carrying an unc-119::CFP
array rescuing ceh-51 and an unc-119::YFP array rescuing end-1,3.
YFP(+), CFP(+) animals were identiﬁed in which all viable progeny
expressed CFP and which segregated gutless embryos (hence end-1
end-3 ceh-51/++ ceh-51). YFP(+), CFP(+) animals were picked in
the next generation and examined for expression of both arrays by
all viable animals. These animals were crossed to rescued tbx-35;
ceh-51 males to generate a quadruple mutant tbx-35; end-1 end-3
ceh-51 strain rescued by an unc-119::mCherry array (tbx-35(+),
ceh-51(+)) and an unc-119::YFP array (end-3(+)). The cup-4::GFP
and pha-4::GFP markers were introduced and the quadruple mutant
genotypes re-segregated.
Microscopy, imaging and laser ablations
Embryos were imaged on agar pads using an Olympus BX-61
equipped with a Canon 350D camera. Images were processed using
Adobe Photoshop 7. In images for birefringent granules and ﬂuores-
cent reporter expression, images from multiple focal planes were
digitally combined. Laser ablationswere performedat theUCRiverside
Microscopy and Imaging Core Facility as described (Lin et al. 2009).
Results
Chromosomal loss of end-1 and end-3 blocks endoderm speciﬁcation
END-1 and END-3 are GATA factors that contain a single zinc ﬁnger
and associated basic domain (Lowry and Atchley, 2000; Maduro et al.,
2005a; Zhu et al., 1997). The end-1 and end-3 genes are located
∼30 kbp apart on chromosome V, apparently the products of an
ancestral gene duplication (Gillis et al., 2007). Deletions that remove
both end-1 and end-3 and a large number of neighboring genes,
deﬁning the Endoderm Determining Region (EDR), result in a one-
fold embryonic arrest and a complete absence of gut (Zhu et al., 1997).
In contrast, single mutants of end-1 and end-3 have only minor effects
on endoderm. The ok558 lesion of end-1, which removes the DNA-
binding domain, results in no apparent phenotype, while the zu247
allele, a missense mutation causing a P202L change in the END-3
DNA-binding domain, and ok1448, which deletes the domain, both
result in mild endoderm defects (5%–9% lacking endoderm; Table 1
and Maduro et al., 2005a; Maduro et al., 2005b). The single end
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selves have only a partial endoderm speciﬁcation defect (Maduro
et al., 2005a; Maduro et al., 2005b). RNAi of end-3 in an end-1mutant
blocked endoderm speciﬁcation in 89–93% of progeny embryos
(Maduro et al., 2005a), but it was not resolved whether the
incomplete penetrance reﬂected the efﬁciency of RNAi targeted to
end-3 or if there are other genes in the EDR that can contribute to
endoderm speciﬁcation. Indeed, a nuclear hormone receptor gene
located in the EDR, R10D12.2/dpr-1 (previously named end-2) could
apparently rescue endoderm speciﬁcation in a small proportion of
transgenic embryos homozygous for a deﬁciency that removes end-1
and end-3 (Zhu et al., 1997).
To directly assess the requirement for end-1 and end-3 in
endoderm speciﬁcation, we constructed double mutants of end-1
(ok558) with end-3(ok1448) and end-3(zu247) (see Materials and
methods). As the same end-1 allele was used for all analyses presented
here, the end-1(ok558) end-3(ok1448) genotype will be referred to as
end-1,3(ok1448) and the end-1(ok558) end-3(zu247) genotype as
end-1,3(zu247). Both end-1,3(ok1448) and end-1,3(zu247) double
mutants failed to make endoderm 100% of the time (n=377 and
n=190) as scored by morphology with DIC microscopy and using
polarized light to detect birefringent gut granules (Figs. 2A–D) (Laufer
et al., 1980). Hence, although the zu247 allele is only a missense
mutation, all endoderm speciﬁcation in end-3(zu247) is dependent on
end-1. Ectopic endodermmade in pie-1(RNAi) embryos also showed a
requirement for end-1,3 in the two strains (Table 1) (Mello et al.,
1992). The majority of end-1,3 embryos (83%, n=124 for end-1,3
(ok1448)) underwent a developmental arrest after completing
elongation, with many of these eventually hatching as arrested L1s;
the remainder arrested as embryos at varying stages of elongation.
The gut, elongation and viability defects were restored to 96–99% of
end-1,3 double mutants by an array carrying end-1(+) and end-3
(+) or end-3(+) alone (Table 1, Fig. 2 and data not shown).Fig. 2. Chromosomal end-1,3 double mutants lack endoderm. (A) DIC appearance of
extrachromosomal transgene array carrying end-1(+) and end-3(+) (referred to as an end-1
Polarized light micrograph showing appearance of birefringent gut granules in the rescued
end-1(ok558) end-3(zu247) embryos. The embryo on the left carries an end-1,3(+) array. (D
wild-type L1 (left) and arrested end-1(ok558) end-3(ok1448) double mutant. The gut in th
shaded in red. The wild-type is approximately 240 μm long. (F) Expression of elt-2::GFP (Fuk
been digitally combined in this panel and panels G, H, J and K. (G, H) Absence of elt-2 ex
Accumulation of gut granule-like material in part of the excretory cell (arrowheads) of an en
1998; Kalb et al., 1998) in a developing end-1,3 embryo carrying an end-1,3(+)array. The ph
expressing cells are from the developing intestine. (K) Absence of the intestinal component o
J. (L) end-1(ok558) end-3(ok1448) embryos arrested with a one-fold appearance following
indicated. (M) Accumulation of large amounts of gut granules in rescued (red outline) and n
In panels J and K, anterior is to the left and dorsal is up.Two additional phenotypes were noted among end-1,3 mutant
embryos. First, ectopic gut granule-like material was observed in the
excretory cell in 11% (n=90) of end-1,3(zu247) and 13% (n=106) of
end-1,3(ok1448) embryos (Fig. 2I). Second, while wild-type L1s were
measured to be 242±4.4 μm (n=12) long, hatched end-1(ok558)
end-3(ok1448) double mutants were only about 75% as long, with an
average length of 175±7 μm (n=19, pb10−8) (Fig. 2E). Such
hatched end-1,3 embryos frequently contained apparent hypodermal
abnormalities (not shown). Excretory-cell granules and a contraction
of embryo length were also reported for mutants in the glo genes,
which have defects in gut granule biogenesis but nonetheless make an
intestine (Hermann et al., 2005). At least one of these, glo-1, is
expressed in the embryonic E lineage and the intestine through
adulthood, and is proposed to be a target of END-1,3 (Hermann et al.,
2005). By in situ hybridization, we detected transcripts for glo-1 in the
E lineage in 86% (n=49) of wild-type embryos at gastrulation stage or
later. In contrast, expression was detected in only 33% (n=42) of
embryos from an end-1,3(ok1448) strain rescued by an array with a
transmission frequency of ∼40%, consistent with the absence of glo-1
expression in all end-1,3 mutant embryos (data not shown). These
results suggest that later embryonic phenotypes of end-1,3 double
mutants result from the absence of functions that are normally
provided to the embryo by the gut, such as osmoregulation or
lysosomal trafﬁcking (Hermann et al., 2005).
In prior studies that examined the fate of E descendants in EDR
deﬁciency embryos or following RNAi of end-1 and end-3, E was
observed to adopt a C-like fate, generating epidermis and bodymuscle
cells instead of gut (Maduro et al., 2005a; Zhu et al., 1997). A small
number of end-3(zu247) mutant embryos appeared to show evidence
of partial transformation to an MS-like fate, suggesting that at least
part of the E lineage can produce ectopic MS-like cells when
endoderm speciﬁcation is compromised (Maduro et al., 2005a). The
chromosomal double end-1,3 mutant embryos were examined forend-1(ok558) end-3(ok1448) embryos. The embryo on the left is rescued by an
,3(+) array). On the middle embryo, internal cavities are indicated by arrowheads. (B)
embryo (left, outlined in red) but not in the mutant embryos (outlined in yellow). (C)
) Gut granules are present only in the rescued embryo (red outline). (E) Newly-hatched
e wild-type has been shaded blue, and the pharynx and hindgut (rectum) have been
ushige et al., 1998) in a wild-type elongated embryo. DIC and ﬂuorescence images have
pression in end-1(ok558) end-3(ok1448) and end-1(ok558) end-3(zu247) embryos. (I)
d-1(ok558) end-3(zu247) arrested embryo. (J) Expression of pha-4::GFP (Horner et al.,
arynx and hindgut (h.g.) components of pha-4 expression are indicated; the remaining
f pha-4 expression in an end-1(ok558) end-3(ok1448) embryo at a similar stage as panel
heat shock overexpression of elt-2. Two embryos that carry an end-1,3(+) array are
on-rescued (yellow outline) embryos. A C. elegans embryo is approximately 50 μm long.
213M. Owraghi et al. / Developmental Biology 340 (2010) 209–221evidence of the tissue types made by E descendants. First, the
formation of internal cavities has previously been associated with
internalization of ectopic C-like cells in skn-1, med-1,2 or tbx-35
mutants, resulting in ectopic epidermis in the descendants (Bower-
man et al., 1992; Broitman-Maduro et al., 2006). We observed such
cavities in 13% (n=176) of end-1(ok558) end-3(zu247) and 15%
(n=124) of end-1(ok558) end-3(ok1448) embryos (Fig. 2A and data
not shown). By comparison, cavities were observed in approximately
30% of med-1,2 and tbx-35 mutants (Broitman-Maduro et al., 2006;
Maduro et al., 2001).
To more precisely evaluate the fate of E descendants in end-1,3
embryos, a laser microbeam was used to isolate early blastomeres in
end-1,3(ok1448) embryos carrying various tissue-speciﬁc reporters.
Expression of nhr-25::YFP, a reporter that is normally expressed in
epidermis (Baugh et al., 2005), did not occur in the embryonic
intestine of intact embryos (n=80), while descendants of isolated C
blastomeres showed expression as expected (5/5 partial embryos).
However, 10/10 isolated E blastomeres from end-1,3(ok1448)
embryos displayed nhr-25::YFP (Table 3). Production of body muscle
cells from isolated E blastomeres was observed in end-1,3(ok1448)
mutant embryos (n=3) as assessed by expression of unc-120::GFP
(Table 3) (Fukushige et al., 2006). Moreover, in intact end-1,3
(ok1448) and end-1,3(zu247) embryos, neither ectopic pharynx
(scored by pha-4::GFP) nor ectopic coelomocytes (cup-4::GFP) were
apparent (Table 2) (Horner et al., 1998; Kalb et al., 1998; Patton et al.,
2005). These results conﬁrm that chromosomal loss of end-1 and end-
3 results causes E to adopt a C-like fate, making body muscles and
epidermal cells. Furthermore, we could ﬁnd no evidence that such
embryos produce ectopic pharynx or coelomocyte cells as would be
consistent with ectopic MS speciﬁcation.
The apparent target of end-1 and end-3 is the GATA factor gene elt-
2 (Fukushige et al., 1998; Maduro et al., 2005a; Maduro and Rothman,
2002). ELT-2 is not essential for embryonic gut speciﬁcation, but is
required for maintenance of the gut fate (Fukushige et al., 1998).
A chromosomally integrated elt-2::GFP reporter was introduced into
the end-1,3 double mutants. Expression of elt-2 was absent in 100%
(n=112) of end-1,3(ok1448) and 100% (n=142) of end-1,3(zu247)
embryos (Figs. 2F–H). Similarly, expression of a reporter for the gut
esterase gene ges-1, a direct target of ELT-2 (Egan et al., 1995), and the
intestine expression of pha-4 (Horner et al., 1998), were both absent
in end-1,3(ok1448) double mutants (n=238 and n=30, respectively;Table 2
Coelomocytes and pharynx cells made in wild-type, mutant and RNAi backgrounds.
Genotype
Wild-type (N2)
pop-1(RNAi)
glp-1(RNAi)
end-1(ok558) end-3(ok1448)
end-1(ok558) end-3(zu247)
end-3(ok1448); pop-1(RNAi)
end-1(ok558) end-3(zu247); pop-1(RNAi)
end-1(ok558) end-3(ok1448); pop-1(RNAi)
end-3(ok1448); glp-1(or178)
end-3(ok1448); glp-1(or178); pop-1(RNAi)
end-1(ok558) end-3(ok1448); glp-1(or178)
end-1(ok558) end-3(ok1448); glp-1(or178); pop-1(RNAi)
end-1(ok558) end-3(ok1448); glp-1(or178); pop-1(RNAi); Ex[end-1,3(+)]
med-1(ok804); med-2(cx9744)
tbx-35(tm1789); ceh-51(tm2123)
med-1(ok804); med-2(cx9744); end-1(ok558) end-3(ok1448)c
med-1(ok804); med-2(cx9744); end-1(ok558) end-3(ok1448); pop-1(RNAi)c
tbx-35(tm1789); end-1(ok558) end-3(ok1448) ceh-51(tm2123)
tbx-35(tm1789); end-1(ok558) end-3(ok1448) ceh-51(tm2123); pop-1(RNAi)
a Some data are from Broitman-Maduro et al. 2009.
b Expression of pha-4 in gut and/or rectum cells (if present) was not included.
c Embryos were also homozygous for dpy-11(e224).Figs. 2J, K). Hence, end-1 and end-3 together are necessary for
activation of elt-2 and its downstream targets.
To test if overexpression of ELT-2 in an end-1 end-3 double mutant
background was sufﬁcient to restore endoderm, we introduced a heat
shock (hs) elt-2 integrated transgene (Fukushige et al., 1998) into the
end-1,3(ok1448) background rescued by a transgenic end-1,3(+)
extrachromosomal array that can be scored for its presence by sur-5::
dsRed expression (Yochem et al., 1998). Among heat shocked
embryos that contained excess gut, 36% (16/44) carried the end-1,3
(+) rescuing array, while the remainder (64%, 28/44) did not,
conﬁrming that overexpression of ELT-2 is sufﬁcient to specify
intestinal fate in the absence of end-1 and end-3 (Figs. 2L, M).
Taken together, these results conﬁrm that end-1 and end-3
together are essential for endoderm speciﬁcation, that E adopts a
C-like fate in end-1,3 double mutants, and that a key contribution of
END-1,3 to intestine fate is the activation of elt-2. Furthermore, the
ability of end-1,3 mutants to elongate and hatch demonstrates the
capacity of the embryo to undergo morphogenesis in the complete
absence of the endoderm.
MS-derived tissues are made in pop-1; end-3 and pop-1; end-1,3
embryos
The nuclear Wnt effector TCF/POP-1 plays a central role in
speciﬁcation of MS. Loss of maternal pop-1 function through the
maternal-speciﬁc allele zu189 or by RNAi results in a penetrant mis-
speciﬁcation of MS as an E-like precursor (Lin et al., 1998; Lin et al.,
1995). Consistent with negative regulation of the end genes by POP-
1 in MS, end-1 and end-3 are expressed ectopically in both MS and E
in pop-1 mutant embryos (Maduro et al., 2005a; Maduro et al.,
2007; Shetty et al., 2005). This repression is direct, as GFP::POP-1
interacts in vivo with extrachromosomal arrays containing either
promoter (Maduro et al., 2002), and a POP-1 binding site is required
for repression of an end-1 transgene reporter in the early MS lineage
(Shetty et al., 2005). What has not been clear from prior studies with
pop-1 and MS fate is whether there is a requirement for POP-1 in MS
in addition to repression of endoderm fate. Indeed, the MS
speciﬁcation genes tbx-35 and ceh-51 are still expressed in MS in
pop-1 mutants (Broitman-Maduro et al., 2006; Broitman-Maduro
et al., 2009), suggesting that the normal pathways for MS
speciﬁcation might still be active.Coelomocytes cup-4::GFPa Pharynx cells pha-4::GFPa,b
3.7±0.2 (105) 50.0±0.9 (21)
0.0±0.0 (50) 21.3±0.8 (18)
nd 23.1±0.6 (15)
4.5±0.1 (65) 49.1±1.0 (10)
4.6±0.1 (77) 51.1±1.3 (15)
6.1±0.2 (77) 28.5±7.0 (22)
9.3±0.2 (80) 43.5±1.3 (23)
10.7±0.3 (77) 44.8±2.2 (17)
nd 21.2±0.8 (18)
nd 9.5±0.8 (75)
nd 25.2±1.0 (17)
nd 16.8±1.1 (93)
nd 1.4±0.3 (40)
0.1±0.0 (34) 31.3±0.6 (26)
0.2±0.0 (124) 30.2±0.5 (44)
0.0±0.0 (52) 29.9±1.1 (12)
1.0±0.2 (57) 22.4±0.9 (24)
0.1±0.0 (122) 30.3±1.0 (21)
0.1±0.1 (35) 22.1±1.4 (19)
Table 3
Production of tissues in laser-operated embryos.
Genotype Blastomeres ablated or isolated Partial embryos making tissues (# of cells)
Coelomocytes
(cup-4::GFP)
Pharynx muscle
(myo-2::GFP)a
Body muscle
(unc-120::GFP)
Epidermis
(nhr-25::YFP)a
Wild-type MS abl. 0/3 (0.0±0.0) – – –
MS iso. 3/3 (4.0±0.0) – – 0/1
E iso. 0/6 (0.0±0.0) – 0/4 (0.0±0.0) 0/6
C iso. – – – 5/5
skn-1(RNAi) MS iso. – – – 3/3
end-3(ok1448) MS abl. 0/5 (0.0±0.0) – – –
E abl. 2/2 (4.0±0.0) – – –
end-3(ok1448); pop-1(zu189)b ABa+MS abl. – 3/3 (weak) – –
ABa+E abl. – 2/2 – –
ABa+MS+E abl. – 0/3 – –
end-3(ok1448); pop-1(RNAi) MS abl. 4/4 (3.0±0.6) – – –
E abl. 5/5 (3.0±0.5) – – –
MS+E abl. 1/4 (0.3±0.2) – – –
end-1(ok558) end-3(ok1448) MS abl. 1/5 (0.2±0.2) – – –
E abl. 5/5 (3.6±0.2) – – –
MS+E abl. 0/3 (0.0±0.0) – – –
MS iso. 5/5 (4.0±0.0)c – 3/3 (18.7 ± 2.0) 0/53
E iso. 0/4 (0.0 ± 0.0)c – 3/3 (15.3±0.7) 10/103
pop-1(zu189)b MS abl. – 1/1 – –
ABa abl. – 0/3 – –
pop-1(RNAi) MS iso. – – – 0/3
E iso. – – – 0/4
end-1(ok558) end-3(ok1448); ABa+MS abl. – 5/5 – –
pop-1(zu189)b ABa+E abl. – 4/4 – –
ABa+MS+E – 0/3 – –
end-1(ok558) end-3(ok1448); MS abl. 3/3 (6.7±0.5) – – –
pop-1(RNAi) E abl. 3/3 (4.7±0.7) – – –
MS+E abl. 0/4 (0.0±0.0) – – –
MS iso. 4/4 (5.0±0.4) – – 0/8
E iso. 6/6 (5.5±0.3) – 6/6 (10.2±1.2) 9/11
ABx+MS abl. – 5/8 – –
ABx+E abl. – 4/6 – –
Abbreviations: abl, ablated; iso, isolated (all other blastomeres ablated); ABx, both daughters of AB were ablated.
a Numbers of cells were not counted because individual cells could not be distinguished.
b Embryos from homozygous pop-1(zu189) dpy-5(e61) mothers (with other mutations as indicated).
c Numbers from experiments on a strain carrying both nhr-25::YFP and cup-4::GFP were included.
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speciﬁcation could be made by evaluating the phenotype of pop-1
mutant embryos in which endoderm speciﬁcation is blocked by
reduction or elimination of end activity. Interpretation of these results
may be complicated by the fact that POP-1 and the Wnt/β-catenin
asymmetry pathway function in many asymmetric cell divisions,
including those that follow the MS-E division within the endomeso-
derm (Huang et al., 2007; Kaletta et al., 1997; Lin et al., 1998; Maduro
et al., 2002; Mizumoto and Sawa, 2007; Schroeder and McGhee,
1998). In the embryo, pop-1 function in MS and E is contributed
maternally, as revealed by the maternal-effect zu189 allele of pop-1
(Lin et al., 1995). In contrast, pop-1(RNAi) abolishes both the zygotic
and maternal contributions of pop-1, resulting in a more severe
phenotype in pop-1(RNAi) embryos compared to pop-1(zu189) (Lin et
al., 1998). Hence, to make the best assessment of MS speciﬁcation, we
have evaluated both pop-1(zu189) and pop-1(RNAi) backgrounds,
and used multiple criteria to evaluate production of MS-derived
tissues.
A further complication could arise if mutation of end-1,3 affected
ratios of POP-1::SYS-1, the primary determinant of POP-1 function as
a repressor or activator (Huang et al., 2007; Phillips et al., 2007).
However, this seems highly unlikely, as zygotic expression of the end
genes is determined by, and occurs downstream of, the activity of
maternal POP-1 and SYS-1 proteins (Huang et al., 2007; Maduro et al.,
2007; Shetty et al., 2005). Nonetheless, we examined med-1-driven
GFP::SYS-1 and GFP::POP-1 reporter strains in an end-1,3(ok1448)
mutant background and saw no apparent effect on SYS-1 or POP-1
protein asymmetries (data not shown) (Huang et al., 2007; Maduro
et al., 2002).Previous results suggested that a potent knockdown of endoderm
speciﬁcation occurs in end-3; pop-1 mutant embryos. END-3 appears
to contribute to end-1 activation (Maduro et al., 2007), and POP-1
makes a positive contribution to end expression in E (Phillips et al.,
2007; Shetty et al., 2005). As a result, although there is also input into
endoderm speciﬁcation by SKN-1, MED-1,2 and PAL-1, loss of pop-1
and end-3 compromises end-1 activation enough that endoderm fails
to be speciﬁed in 91–99% of embryos (Table 1) (Maduro et al., 2007;
Maduro et al., 2005b; Maduro et al., 2001). Because end-3 homo-
zygotes are viable, we performed our ﬁrst studies with end-3; pop-1
embryos, then subsequently with end-1,3; pop-1 embryos when the
double end-1,3 mutants became available. The results of both sets of
experiments, collectively referred to as end; pop-1, are described
below and summarized in Tables 2 and 3.
We examined end-3(ok1448); pop-1(RNAi) and end-1(ok558)
end-3(ok1448); pop-1(RNAi) embryos for production of MS-derived
tissues (Table 2). Using pha-4::GFP to score pharynx cells (Horner
et al., 1998; Kalb et al., 1998), control pop-1(RNAi) embryos
displayed an average of 21.3±0.8 (n=18) pharynx cells (compared
with wild-type, 50.0±0.9, n=21), consistent with the loss of MS-
derived pharynx resulting from an MS-to-E transformation (Figs. 2J
and 3C). In contrast, end-3(ok1448); pop-1(RNAi) embryos
contained 28.5±7.0 (n=22) pharynx cells (pb0.0002 compared
with pop-1(RNAi) alone), while end-1,3(ok1448); pop-1(RNAi) and
end-1,3(zu247); pop-1(RNAi) embryos had 44.8±2.2 (n=17) and
43.5±1.3 (n=23) pharynx cells each (pb10−14 compared with
pop-1(RNAi) alone) (Fig. 3G and data not shown). From the absence
of gut, and the presence of signiﬁcantly more pharynx cells in end-
1,3; pop-1 embryos over pop-1 alone, the most straightforward
Fig. 3. Embryos lacking end and pop-1 function makeMS-type pharynx. (A) Polarized light image of a ﬁeld of end-1(ok558) end-3(ok1448); glp-1(or178ts) embryos raised at the non-
permissive temperature for or178 and treated with pop-1(RNAi). The two embryos on the left (outlined in red) carry an end-1,3(+) transgene and are the only embryos making gut.
(B) Fluorescence image of the same embryos in panel A showing pha-4::GFP expression (Horner et al., 1998; Kalb et al., 1998). Expression in the two rescued embryos (red outline) is
from gut cells, while in the remaining embryos expression is from GLP-1-independent pharynx cells (an average of 16.8 ± 1.1 cells, n=93). Hindgut cells (as seen in panels K–N) are
not made in strong glp-1mutants due to a transformation of ABp to ABa (Mello et al., 1994). (C) GFP overlay of pha-4::GFP expression in a pop-1(RNAi) embryo. The bright signals in
large nuclei are gut nuclei (conﬁrmed by polarized light birefringence), while the remaining expression is fromhindgut cells (h.g.) andABa-derived pharynx (an average of 21.3 ± 0.8
cells, n=18). (D) Elongated wild-type embryowith grinder (gr) indicated. (E) Arrested pop-1(zu189) dpy-5(e61) embryo from a pop-1 dpy-5mother. (F) Arrested end-1(ok558) end-
3(ok1448); pop-1(zu189) dpy-5(e61) embryo from an end-1,3; pop-1 dpy-5mother rescued by an end-1,3(+) transgene. The grinder (gr) within a posterior pharynx-like structure is
indicated. (G) Expression of pha-4::GFP in an end-1(ok558) end-3(ok1448); pop-1(RNAi) embryo in hindgut (h.g.) and pharynx (average of 44.8 ± 2.2 pharynx cells, n=17). (H–J)
myo-2::GFP expression (Okkema et al., 1993) showing presence of ABa-andMS-derived portions of pharynx in wild-type (H) and end-1,3; pop-1 (J) embryos, but lacking MS-derived
pharynx in a pop-1mutant (I). (K–N) pha-4::GFP expression in chromosomal mutant backgrounds that block MS speciﬁcation, with and without pop-1(RNAi). (K, L)med-1(ok804);
med-2(cx9744); dpy-11(e224) end-1(ok558) end-3(ok1448) background. (M,N) tbx-35(tm1789); end-1(ok558) end-3(ok1448) ceh-51(tm2123) background. In these mutant
backgrounds, the number of pha-4::GFP-expressing cells is actually reduced from ∼30 to∼22when pop-1(RNAi) is added, owing to an apparent requirement for pop-1 in ABa-derived
pharynx (Table 2). An additional requirement for pop-1 in morphogenesis (Lin et al., 1998) results in dispersal of pha-4::GFP-expressing cells in panels L and N. Embryos in most
panels have been oriented with anterior to the left and dorsal up.
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embryos.
As MS-derived pharynx is produced independently of maternal
GLP-1 (Priess et al., 1987), we examined whether glp-1 was required
for production of extra pharynx cells in end; pop-1 embryos. First,
end-1,3(ok1448); glp-1(or178); pop-1(RNAi); Ex[end-1,3(+)] embry-
os, rescued for endoderm speciﬁcation by a transgene array, made
almost no pharynx cells (1.4±0.3 cells, n=40) (Figs. 3A, B). This
control result is consistent with the loss of both AB- and MS-derived
pharynx in glp-1; pop-1mutant embryos (Lin et al., 1995). In contrast,
non-rescued end-1,3(ok1448); glp-1(or178); pop-1(RNAi) embryos
made 16.8±1.1 (n=93) pharynx cells (pb10−24) while end-3
(ok1448); glp-1(or178); pop-1(RNAi) embryos made 9.5±0.8
(n=75) cells (pb10−13) (Figs. 3A, B). The complement of GLP-1-
independent pharynx was 21.3±0.8 (n=18) in glp-1(RNAi) embry-
os, 21.2±0.8 (n=18) in end-3(ok1448); glp-1(or178) embryos,
and 25.2±1.0 (n=17) in end-1,3(ok1448); glp-1(or178) embryos(Table 2). Hence, ∼45% and ∼67% of the number of GLP-1-
independent pharynx cells are restored in end-3(ok1448); pop-1
(RNAi) and end-1,3(ok1448); pop-1(RNAi) embryos, respectively.
To look for evidence that these pharynx cells were capable of
undergoing organogenesis, we looked for a posterior pharynx in end-
1,3(ok1448); pop-1(zu189) embryos that also carried a myo-2::GFP
pharynx muscle reporter (Okkema et al., 1993). At least a partial
grinder was visible in 23% (n=74) of end-1,3(ok1448); pop-1(zu189)
embryos, but this was never seen in sibling embryos that were
rescued for end-1,3 by a transgene array (n=43) (Figs. 3D–F, H–J).
This suggests that the additional pharynx cells made in end-1,3; pop-1
embryos can sometimes undergo organogenesis to generate part of
the posterior pharynx.
To examine the origin of the additional pharynx cells made in end;
pop-1(RNAi) embryos, we performed laser ablations on embryos using
end-3(ok1448); pop-1(zu189) and end-1(ok558) end-3(ok1448); pop-1
(zu189) strains carrying a cytoplasmic myo-2::GFP reporter, which
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and E together led to production of no pharynx muscle (n=3 for each
genotype), ablation of only ABa+MS or ABa+E resulted in production
of pharynxmuscle in partial embryos of each genotype, althoughmyo-2
expression in ABa+MS ablated end-3(ok1448); pop-1(zu189) embryos
was somewhat weaker (Table 3). In a separate experiment, ablation of
the AB daughters plus either MS or E in end-1,3(ok1448); pop-1(RNAi)
embryos resulted inmyo-2 expression in 5/8 and 4/6 partial embryos,
respectively. These results suggest that bothMS and E can produceMS-
like tissues in end-3; pop-1 and end-1,3; pop-1 embryos.
Next, we tested for embryonic production of coelomocytes, which
comprise four cells derived exclusively fromMS (Sulston et al., 1983).
As scored by a cup-4::GFP marker (Patton et al., 2005), pop-1(RNAi)
embryos made no coelomocytes (n=50) compared with wild-types,
which showed an average of 3.7±0.2 (n=105), and end-1,3mutants,
which showed an average of ∼4.5 cells (Table 2, Figs. 4A–C). In
contrast, end-3(ok1448); pop-1(RNAi) embryos made an average of
6.1± 0.2 (n=77) coelomocytes, end-1,3(ok1448); pop-1(RNAi)
embryos made an average of 9.3±0.2 (n=80), and end-1,3(zu247);
pop-1(RNAi) embryos made an average of 10.7±0.3 (n=77) (Figs.
4E, F and data not shown). Using a laser microbeam, we ablatedMS, E,
or both in end-3(ok1448) and end-1,3(ok1448) backgrounds with or
without pop-1(RNAi). The end-3 and end-1,3 backgrounds showed
production of coelomocytes only from MS, while end-3; pop-1 and
end-1,3; pop-1 showed production of coelomocytes from both MS
and E (results summarized in Table 3). Taken together, these results
suggest that coelomocytes and GLP-1-independent pharynx are made
by both MS and E in end; pop-1 embryos. This suggests that POP-1 is
not essential for production of mesoderm tissue from MS, and
furthermore, that POP-1 and/or END-1,3 may repress MS fate in the
E cell. The failure to obtain a high number of completely restored MS-
derived pharynxes implies additional requirements for POP-1 func-
tion in MS lineage development; this is consistent with known
involvement of the Wnt/β-catenin asymmetry pathway in pharynx
lineages in MS (Kaletta et al., 1997).
Restored MS-like fates in end-1,3; pop-1 mutants require normal
pathways for MS speciﬁcation
The simplest explanation for the origin of MS-derived pharynx
and coelomocytes in end; pop-1 mutants is that these arise through
activation of the same genes that specify MS in wild-type embryos.
However, it is possible that mesoderm speciﬁcation is activated later
by some default mechanism in response to the absence of POP-1 and
END-1,3. We have shown that med-1,2 together, and tbx-35; ceh-51Fig. 4. Coelomocytes are made in end-1,3; pop-1mutant embryos. All embryos carry a cup-4:
accumulation of cup-4::GFP expression in four coelomocytes (the top two are adjacent).
coelomocytes in pop-1(RNAi) and med-1(ok804); med-2(cx9744) embryos, in which a pen
Maduro et al., 2001). (E, F) Supernumerary coelomocytes are made in end-3(ok1448); pop-
(ok558) end-3(ok1448); pop-1(RNAi) embryos (average of 10.7 ± 0.3 cells, n=77). (G, H) Lo
(ok1448); pop-1(RNAi) and tbx-35(tm1789); end-1(ok558) end-3(ok1448) ceh-51(tm2123);together are essential for production of coelomocytes and GLP-1-
independent pharynx (Figs. 3K, M and 4D) (Broitman-Maduro et al.,
2009). To conﬁrm that coelomocytes and pharynx cells made in end;
pop-1 mutant embryos are the result of normal MS speciﬁcation, we
constructed quadruple med-1(ok804); med-2(cx9744); end-1(ok558)
end-3(ok1448) and tbx-35(tm1789); end-1(ok558) end-3(ok1448)
ceh-51(tm2123) mutant strains carrying pha-4::GFP or cup-4::GFP
(see Materials and methods). As summarized in Table 2, both
quadruple-mutant backgrounds resulted in loss of MS-derived
coelomocytes (none, for med-1,2; end-1,3 (n=52), and 0.1±0.0
(n=122) for tbx-35; end-1,3 ceh-51), similar to med-1,2 or tbx-35;
ceh-51 alone. However, even though end-1,3; pop-1 embryos made
an average of 10.7±0.3 (n=77) coelomocytes as reported above,
addition of pop-1(RNAi) resulted in very few coelomocytes (1.0±0.2
in the case of med-1,2; end-1,3; pop-1(RNAi) or nearly none (0.1±
0.1, n=35) in the case of tbx-35; end-1,3 ceh-51 (Figs. 4G, H). A
similar pattern was observed for expression of pha-4::GFP: While
med-1,2; end-1,3 and tbx-35; end-1,3 ceh-51 quadruple mutants
made 29.9±1.1 (n=12) and 30.3±1.0 (n=21) pharynx cells each,
addition of pop-1(RNAi) did not result in an increase in pharynx cells
as was seen with end-1,3; pop-1 (Figs. 3C, L, N). Indeed, the quadruple
mutant+ pop-1(RNAi) backgrounds produced even fewer pharynx
cells (22.4±0.9 (n=24) and 22.1±1.4 (n=19) than the ∼30 cells in
the med-1,2 or tbx-35; ceh-51 backgrounds, comparable to pop-1
(RNAi) alone (21.3±0.8, n=18), and demonstrating a requirement
for the Wnt/β-catenin asymmetry pathway in production of pharynx
cells from the AB lineage (Kaletta et al., 1997; Lin et al., 1998). These
results show that the MS-derived tissues made in end-1,3; pop-1
embryos require the genes that normally specify MS. The detection of
greater than 8 coelomocytes (as would be expected from 2×MS cells
in the embryo) further suggests that POP-1 plays a role in MS lineage
asymmetries that give rise to coelomocyte precursors, a phenomenon
that has been reported for postembryonically-speciﬁed coelomocytes
(Amin et al., 2009).
E produces epidermal tissue as well as MS tissues in end; pop-1 embryos
It is possible that in addition to MS-type cells, MS and/or E in end;
pop-1 mutant embryos could make cells that are normally derived
from C. The Caudal-like regulator PAL-1, which speciﬁes the C and D
fates, is present in the early MS and E lineages, and is responsible for
the C transformations that result when MS and E speciﬁcation is
compromised by mutation in the SKN-1/MED-1,2 pathway (Broit-
man-Maduro et al., 2006; Broitman-Maduro et al., 2009; Hunter and
Kenyon, 1996; Maduro et al., 2005a). To evaluate this possibility, we:GFP coelomocyte-speciﬁc marker (Patton et al., 2005). (A) Wild-type embryo showing
(B) Normal coelomocytes in an end-1(ok558) end-3(ok1448) mutant. (C, D) Loss of
etrant mis-speciﬁcation of MS occurs (Broitman-Maduro et al., 2009; Lin et al., 1995;
1(RNAi) embryos (average of 6.1 ± 0.2 cup-4::GFP-expressing cells, n=77) and end-1
ss of coelomocytes inmed-1(ok804); med-2(cx9744); dpy-11(e224) end-1(ok558) end-3
pop-1(RNAi) embryos. Faint yellow signal in some panels corresponds to gut granules.
Fig. 5. Expression of MS speciﬁcation factors in pop-1(RNAi) and end-1,3 mutant
backgrounds. (A,B) Expression of a tbx-35::GFP reporter in wild-type and pop-1(RNAi)
embryos. 100% (n=40) of expressing embryos showed MS lineage-only expression in
wild-type, while 12% (n=67) of tbx-35::GFP-expressing pop-1(RNAi) embryos showed
ectopic expression in the E lineage as shown; 75% of embryos overall had weak E
lineage expression. (C–F) in situ hybridization with a ceh-51 probe. (C) Wild-type
staining pattern observed in 91% of embryos in the early MS lineage (MS2 as shown
here, or MS4; n=101). (D) Ectopic expression of ceh-51 in the early E lineage was
observed in 86% (n=44) of pop-1(RNAi) embryos (the remainder showed either
normal expression or did not stain). Results in C and D were previously reported
(Broitman-Maduro et al., 2009). (E) Weak ectopic expression of ceh-51 in the E lineage
(at E2, as shown here; ectopic expression was also observed at E4), as seen in 41%
(n=209) of progeny from end-1(ok558) end-3(ok1448) mothers carrying an end-1,3
(+) rescuing array. As this array is transmitted to ∼50% of the progeny, ∼80% of end-1,3
mutant embryos showed activation of ceh-51 in the E lineage. The remaining embryos
showed wild-type expression (MS only). (F) Expression of ceh-51 in MS and E was seen
in 88% (n=45) of end-3(ok1448); pop-1(RNAi) embryos. The remaining embryos were
either unstained or appeared normal.
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reporter, to mark coelomocytes, and an nhr-25::YFP reporter to mark
epidermal cells (Baugh et al., 2005; Patton et al., 2005); the two
reporters can be distinguished with appropriate ﬁlter sets (Miller
et al., 1999). We used a laser microbeam to isolate MS or E and
evaluated whether the resultant partial embryos produced epidermal
cells, coelomocytes or both. MS blastomeres isolated from end-1,3
(ok1448); pop-1(RNAi) embryos generated coelomocytes but not
epidermal cells (n=4), while isolated E blastomeres made coelomo-
cytes all the time (6/6 embryos) and, simultaneously, epidermal cells
part of the time (4/6 embryos). Therefore, in end; pop-1 mutant
embryos, E, but not MS, frequently adopts a mixed fate that includes
production of tissues normally made by MS and C.
Early MS markers are expressed in E in pop-1 and end-1,3 mutant
embryos
The production of pharynx cells from E in end-1,3; pop-1(RNAi)
embryos suggests that POP-1 contributes to repression ofMS fate in E. A
role for POP-1 in repressing MS fate in E would explain why Wnt/β-
catenin asymmetry mutants, which act upstream of POP-1, cause a
transformation of E to MS, while loss of end-1,3 results in an E to C
transformation (Kaletta et al., 1997; Maduro et al., 2005a; Rocheleau et
al., 1997; Rocheleau et al., 1999; Thorpe et al., 1997; Zhu et al., 1997).
We previously failed to detect ectopic expression of the MS speciﬁca-
tion gene tbx-35 in the E lineage in pop-1mutant embryos, either by in
situ hybridization or a tbx-35::GFP reporter with 605 bp of putative tbx-35 promoter (Broitman-Maduro et al., 2006). However, such ectopic
expression was observed with a tbx-35::GFP reporter with 734 bp of
promoter (Premnath Shetty and Rueyling Lin, personal communica-
tion; we reproduced this result with their reporter as shown in Figs. 5A,
B). It was recently reported that pop-1(RNAi) embryos frequently
showed expression of endogenous ceh-51 and a ceh-51::GFP reporter in
the early E lineage (Broitman-Maduro et al., 2009) (Figs. 5C, D). The
ability of E to consistently produce MS tissues in end-1,3; pop-1mutant
embryos suggested to us that loss of end-1,3may synergize with loss of
pop-1 to result in activation ofMS genes. Indeed, we detected low levels
of ceh-51 transcripts in the E lineage in end-1,3(ok1448) mutants,
consistent with a parallel role for END-1,3 in repressing MS fate (Fig.
5E). Furthermore, expression of ceh-51was strong in both the E andMS
lineages in end-3; pop-1(RNAi) embryos, though no further enhance-
ment of the expression seen in pop-1(RNAi) alone was noted (Fig. 5F).
Taken together, these results conﬁrm that the MS tissues made by E in
end; pop-1 embryos correlatewith ectopic activation ofMS speciﬁcation
in E, and they also provide evidence that POP-1 and END-1,3 contribute
to the repression of early MS genes in the E lineage.
Discussion
Regulatory interactions in the C. elegans endomesoderm gene
regulatory network
An updated gene network for C. elegans endomesoderm speciﬁca-
tion is shown in Fig. 6. Although this network focuses on EMS and its
daughters, secondarymesodermgenerated by ABa is included because
it is induced by MS and involves downstream target genes that are
shared with MS (Priess et al., 1987; Roy Chowdhuri et al., 2006; Smith
and Mango, 2007). The network features early maternal factors that
act combinatorially to direct blastomere-speciﬁc activation of tran-
siently-expressed cell speciﬁcation factors, which ultimately results in
activation of stably-expressed tissue/organ identify factors in their
descendants (Labouesse and Mango, 1999; Maduro, 2006; Maduro,
2008; Maduro and Rothman, 2002). Thematernal inputs include SKN-
1 (Bowerman et al., 1992; Maduro et al., 2001), POP-1 (Huang et al.,
2007; Lin et al., 1995; Shetty et al., 2005), the Wnt/β-catenin
asymmetry pathway that acts downstream of the P2-EMS interaction
(Bei et al., 2002; Huang et al., 2007; Phillips et al., 2007; Rocheleau
et al., 1997; Rocheleau et al., 1999; Thorpe et al., 1997), and the weak
contribution by PAL-1 (Maduro et al., 2005b). Also included is the
weak maternal contribution of MED-1,2 (Maduro et al., 2007), the
evidence for which has been disputed by others (Captan et al., 2007).
Within EMS, the only genes in the network are zygotic med-1 and
med-2 (Maduro et al., 2001), and an unknown Delta-Serrate-Lag
(DSL) gene that mediates the GLP-1/Notch-dependent cell–cell
interaction that speciﬁes pharynx from ABa (Mello et al., 1992; Priess
et al., 1987). TheMS/E zygotic factors as discussed above are activated
combinatorially by the SKN-1 pathway and Wnt/β-catenin asymme-
try pathway: These are end-1 and end-3, which specify E, and tbx-35
and ceh-51, which specify MS (Broitman-Maduro et al., 2009; Maduro
et al., 2005a). As tissue/organogenesis factors, we have included the
muscle regulatory network consisting of HND-1/Hand, HLH-1/MyoD,
and UNC-120/SRF (Fukushige et al., 2006), the pharynx identity factor
PHA-4/FoxA (Gaudet andMango, 2002; Kaltenbach et al., 2005), genes
that direct speciﬁcation of pharynx cell subtypes (CEH-22/Nkx2.5 and
HLH-6) (Okkema and Fire, 1994; Okkema et al., 1993; Raharjo and
Gaudet, 2007; Vilimas et al., 2004), and factors required for
speciﬁcation of AB-derived pharynx (TBX-37/38) (Good et al., 2004)
and AB-derived pharynxmuscle (TBX-2) (Roy Chowdhuri et al., 2006;
Smith and Mango, 2007). Based on genetic evidence that TBX-35 and
CEH-51 deﬁne MS-derived muscle and pharynx, we have connected
these regulators directly to the muscle network and pha-4, although
evidence for direct interaction has not yet been obtained. Rather, the
ability of PAL-1 to directly activate hlh-1 in the C lineage strongly
Fig. 6. Updated gene regulatory network for C. elegans endomesoderm generated with BioTapestry (Longabaugh et al., 2009) and modiﬁed in Adobe Photoshop. Some of the
connections shown have been established at the protein–DNA level, while others have been inferred from genetic analysis. See Discussion for further details.
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lineage (Broitman-Maduro et al., 2009; Lei et al., 2009). As markers of
terminal differentiation, the network includes as examples the
pharynx muscle myosin gene myo-2, the body muscle myosin gene
myo-3, the gut esterase gene ges-1, and the gut-expressed phosphatase
gene pho-1 (Fukushige et al., 2005; Kennedy et al., 1993; Okkema et al.,
1993). The elt-7 GATA factor is included, as it is activated at the same
time as elt-2 and may be involved in parallel functions with ELT-2
(Maduro and Rothman, 2002), and mutation of elt-7 was reported to
result in a decrease of intestinal expression of pha-4 (Murray et al.,
2008). The elt-2 paralog elt-4 appears to be non-functional and has not
been included (Fukushige et al., 2003). As we have focused on early
speciﬁcation events, themodel does not includemanyother regulators
known to be involved in pharynx and intestine development; these
have been described in recent reviews (Mango, 2007; McGhee, 2007).
From the studies presented here, we have included the apparent
roles of END-1,3 in repression of ceh-51 and the role of POP-1 in
repression of tbx-35. As derepression of tbx-35 was not complete in a
pop-1 mutant background, the model retains repression of tbx-35 by
an unknown Wnt-dependent repressor, accounting for persistent
differences between the two EMS daughters in the absence of pop-1
(discussed below). As the results presented here also do not require a
positive input of POP-1 in speciﬁcation of MS, it is not included. We
note that this differs from the related nematode C. briggsae, in which an
apparent positive role for POP-1, in parallel with SKN-1, is implied by
RNAi knockdown experiments (also discussed below) (Lin et al., 2009).
A relatively mild phenotype of mutants lacking endoderm
We have reported the construction of a bona ﬁde end-1 end-3
double mutant strain and shown that it results in a complete failure ofendoderm speciﬁcation, as predicted by prior experiments (Maduro
et al., 2005a; Zhu et al., 1997). It might be expected that the complete
mis-speciﬁcation of a germ layer would result in profound changes to
the remainder of embryonic development, but end-1,3 mutants
demonstrated a surprisingly mild phenotype, sometimes hatching
into (inviable) larvae. By comparison, in Drosophila, loss of the
endoderm (midgut) through mutation of the GATA factor serpent
resulted in embryos that began gastrulation normally but eventually
arrested, with midgut progenitors adopting ectodermal (hindgut and
foregut) fates (Reuter, 1994). The mild phenotype of C. elegans end-1,
3mutants explains why smaller deletions removing end-1,3 alone (as
opposed to large deletions removing hundreds of genes) were not
isolated in screens for penetrant zygotic endoderm-defective
mutants, if the design of the screens assumed that mis-speciﬁcation
of endoderm would result in a strict embryonic lethality (Maduro
et al., 2005a; Zhu et al., 1997).
In C. elegans end-1,3 mutant embryos, the transformed descen-
dants of E are capable of an otherwise fairly normal morphogenesis
of the embryo. In normal development, the E daughter cells are the
ﬁrst to ingress during gastrulation (Knight and Wood, 1998; Nance
et al., 2005). The ability of most end-1,3(−) embryos to elongate
suggests that there are mechanisms that can direct early gastrulation
movements within the early E lineage independently of E speciﬁ-
cation, or that errors made during early E gastrulation are
compensated by the embryo, or a combination of both mechanisms.
Previous studies have used Wnt/β-catenin pathway mutants to
perturb E speciﬁcation and gastrulation (Lee et al., 2006; Rohrsch-
neider and Nance, 2009), but these mutants may have effects
outside of the E lineage. Hence, it may be that the chromosomal end-
1,3 double mutant will provide a new resource to further dissect the
connection between gut speciﬁcation and morphogenesis. It is also
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tions that the intestine makes to development, as end-1,3 mutants
had later phenotypes that are also seen in lysosomal trafﬁcking
mutants (Hermann et al., 2005).
A hierarchy of speciﬁcation pathways and reinforcement of fate choices
Prior work on MS speciﬁcation, and the analysis reported here,
highlight the ability of blastomere speciﬁcation pathways to exhibit
phenotype prevalence. Normally, speciﬁcation of MS and E is driven
by activation of tbx-35/ceh-51 in MS, and end-1,3 in E (Broitman-
Maduro et al., 2006; Broitman-Maduro et al., 2009; Maduro et al.,
2005a). In pop-1mutant embryos, end-1 and end-3 become activated
in MS, but tbx-35 and ceh-51 continue to be activated in MS as well
(Broitman-Maduro et al., 2009; Maduro et al., 2007; Shetty et al.,
2005). As well, maternal PAL-1 protein, which speciﬁes the C lineage,
is present in the early MS and E lineages (Hunter and Kenyon, 1996).
Hence, in pop-1mutant embryos, the factors that specify E, MS and C
all coexist within MS, and yet a high-penetrance MS to E transforma-
tion results in such embryos (Lin et al., 1995). Here we have shown
that when end-1 and end-3 are removed in pop-1 mutant embryos,
MS can now be speciﬁed by TBX-35 and CEH-51. In mutants for skn-1,
the meds, or tbx-35/ceh-51, MS adopts a C-like fate (Bowerman et al.,
1992; Broitman-Maduro et al., 2006; Broitman-Maduro et al., 2009;
Maduro et al., 2001). Taken together, this reveals a hierarchy of
ENMSNC fates (Fig. 7). This is reminiscent of the posterior prevalence
of Hox genes, in which the most posteriorly expressed Hox gene
controls regional identity when multiple Hox genes are forcibly
coexpressed, though it is almost certainly not the result of a similar
mechanism (Capovilla and Botas, 1998; Yekta et al., 2008).
Unlike MS, which adopts an apparently strict MS, E or C fate in
various mutant backgrounds (Bowerman et al., 1992; Broitman-
Maduro et al., 2009; Lin et al., 1995), the E lineage can apparently
adopt a mixed fate. We found that in an end-1,3; pop-1 mutant
background, E makes MS tissues (coelomocytes and pharynx) in all
embryos, and epidermal cells, characteristic of C, some of the time (4/
6 embryos). There are other examples of mixed E fates from prior
studies. In end-3 mutants, a small number of embryos showed
apparent “half-guts” in which only one half of the intestine was
present (Maduro et al., 2005a). In at least one lineage recording of an
end-3(zu247) embryo, an E grand-daughter followed a lineage pattern
that resembled anMS grand-daughter (Maduro et al., 2005a). The end
genes are still sensitive to POP-1 repression in Ea (Maduro et al.,Fig. 7. Summary of fate hierarchies revealed by EMS daughter cell fate transformations in va
1995); loss ofWnt/MAPK function causes an E toMS transformation (Rocheleau et al., 1997;
E appears to adopt either an E or C fate (Bowerman et al., 1992; Maduro et al., 2001); loss of e
tbx-35 and ceh-51 results in a transformation of MS to C (Broitman-Maduro et al., 2009); a
apparent mixed fate from E that is a combination of MS and C fates (this work).2007), suggesting that it is possible for Ea and Ep to adopt different
fates if end activity is partly compromised, but this mechanism does
not explain how E can make both MS and C tissue types in a single
embryo. Our analysis did not ﬁnd evidence of production of C tissues
from MS in end-1,3; pop-1 embryos. While we detected similar levels
of ceh-51 expression in the MS and E lineages in pop-1(RNAi) embryos
(Figs. 5C, D), this was not the case for tbx-35, in which a tbx-35::GFP
reporter was activated only weakly (Figs. 5A, B) and which was not
detected ectopically in E at all with a different reporter and in situ
hybridization (Broitman-Maduro et al., 2006). The MS and E
expression of ceh-51::GFP in pop-1(RNAi) embryos was found to be
dependent on tbx-35 (Broitman-Maduro et al., 2009), suggesting that
some amount of TBX-35 is ectopically expressed in E in pop-1(RNAi)
embryos, but it is at lower levels in E than in MS. The conclusion is
that some differences between MS and E are still present in pop-1-
depleted embryos.
These results nonetheless provide further evidence that Wnt-
signaled POP-1 and END-1,3 also actively repress MS speciﬁcation in
E, perhaps as another Wnt-dependent mechanism to enforce an
endodermal fate. Within MS, POP-1 is not modiﬁed by the Wnt/β-
catenin asymmetry pathway, and end-1,3 are repressed by POP-1,
permitting the MEDs to activate tbx-35 and the TBX-35 target ceh-51
(Broitman-Maduro et al., 2006; Broitman-Maduro et al., 2009). We
recently reported that while ceh-51 activation is completely depen-
dent on the MEDs for activation, tbx-35 mutants still activate ceh-51
at reduced levels, suggesting that another activator works in parallel
with TBX-35 (Broitman-Maduro et al., 2009). Knockdown of pop-1 by
RNAi in a tbx-35 mutant background resulted in abrogation of ceh-
51::GFP expression, suggesting that this second factor is dependent on
POP-1 (Broitman-Maduro et al., 2009). Hence, there is some evidence
that unmodiﬁed POP-1 in MS contributes to MS fate, but this
contribution is not at all evident from the phenotype data (as MS
fate is restored to end-1,3; pop-1mutant embryos), and it is similarly
not clear how POP-1 could activate expression of ceh-51 in the MS
daughters at equal levels, given that POP-1 asymmetry exists in MSa/
p (Lin et al., 1998; Maduro et al., 2002).
Comparisons between C. briggsae and C. elegans: network evolution
In contrast to C. elegans, a positive contribution of POP-1 to MS fate
was found in the related nematode C. briggsae. Although the
embryonic lineages of C. elegans and C. briggsae are highly similar
(Zhao et al., 2008), there are notable differences in the mechanisms ofrious mutant backgrounds. Loss of pop-1 results in an MS to E transformation (Lin et al.,
Thorpe et al., 1997); for skn-1 ormed-1,2mutant embryos, MS adopts a C-like fate, while
nd-1,3 results in an E to C transformation (Maduro et al., 2005a; Zhu et al., 1997); loss of
nd loss of end-1,3 and pop-1 together results in a restored partial MS lineage, and an
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types. C. elegans skn-1 mutants show a loss of MS and E tissues
(Bowerman et al., 1992). In C. briggsae, knockdown of Cb-skn-1
resulted in a more penetrant loss of endoderm, while GLP-1-
independent pharynx was still made from MS (Lin et al., 2009).
Knockdown of Cb-pop-1 resulted in production of GLP-1-independent
pharynx from both MS and E, and when Cb-skn-1(RNAi) and Cb-pop-1
(RNAi) were performed simultaneously, both MS and E failed to make
pharynx (Lin et al., 2009). Hence, there is a positive function for Cb-
POP-1 in speciﬁcation of MS fate in parallel with Cb-SKN-1, and this
mechanism is very different from C. elegans. Here we have conﬁrmed
that the primary contribution of Ce-POP-1 to MS speciﬁcation is
repression of Ce-end-1,3, as loss of Ce-pop-1 is compatible with MS
speciﬁcation if the Ce-ends are also mutated. While the mechanistic
basis for these interspeciﬁc phenotype differences has yet to be
elucidated, comparisons between the two species have already
revealed ﬂexibility in how the same genes can function differently
in the same combinatorial speciﬁcation events, and shown that for at
least some apparently hardwired cell fate decisions, there is more
than one way of accomplishing the same developmental endpoint. To
this end, the weaker ‘reinforcing’ functions that have been identiﬁed
in C. elegans may, in other species, be the primary mechanisms that
determine blastomere fates.
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